Product Information

JORNAY PM 80 MG CAPSULE is a brand product labeled by Ironshore Pharmaceuticals Inc., priced at $15.3991 per EA under NDC 71376020403. Its NADAC has been published 344 times since Apr 22, 2020.

FDA first approved this application on Aug 8, 2018.

The High Outlier badge above means this manufacturer's average price in the Methylphenidate Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

JORNAY PM 80 MG CAPSULE

Methylphenidate Hydrochloride
$15.3991per EA
High Outlier
DEA Schedule CII

Strength

80 mg/1

NDC

71376020403

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Approval Type

New Drug (NDA)

FDA Application

NDA209311

FDA Approved

8/8/2018

On Market Since

6/1/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for JORNAY PM 80 MG CAPSULE has been published 344 times since Apr 22, 2020, and over the history we have for it it has risen 30.9%. The table below summarizes its recorded NADAC range and movement.

Current price$15.3991 per EA
All-time high$15.4053 (Jun 10, 2026)
All-time low$11.7598 (Apr 22, 2020)
52-week high$15.4053
52-week low$14.9466
Median price$13.7983
Average price$13.8662
Largest weekly change+6.1% (Aug 5, 2020)
Weeks tracked344
Tracking sinceApr 22, 2020

Price History

1W

+0.0%

1M

+0.0%

3M

-0.0%

6M

-0.0%

1Y

+3.0%

3Y

+11.6%

5Y

+18.6%

All

+30.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methylphenidate Hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of JORNAY PM 80 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for JORNAY PM 80 MG CAPSULE, manufactured by Ironshore Pharmaceuticals Inc., is $15.3991 per EA (NDC 71376020403), effective Nov 18, 2026.

How has the price of JORNAY PM 80 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for JORNAY PM 80 MG CAPSULE has risen 30.9%. It has been tracked across 344 weekly CMS publications since Apr 22, 2020.

What are the highest and lowest recorded NADAC prices for JORNAY PM 80 MG CAPSULE?

Since Apr 22, 2020, the NADAC for JORNAY PM 80 MG CAPSULE has ranged from a low of $11.7598 (Apr 22, 2020) to a high of $15.4053 (Jun 10, 2026), with a median of $13.7983 per EA.

Are there cheaper alternatives to JORNAY PM 80 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of JORNAY PM 80 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures JORNAY PM 80 MG CAPSULE?

JORNAY PM 80 MG CAPSULE (NDC 71376020403) is labeled by Ironshore Pharmaceuticals Inc., and CMS classifies it as a brand product.